• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Predictive Oncology Inc (NQ: POAI )

    0.9001 -0.0299 (-3.22%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 174,635
    Open 0.9300
    Bid (Size) 0.9100 (1)
    Ask (Size) 0.9500 (100)
    Prev. Close 0.9300
    Today's Range 0.9000 - 0.9798
    52wk Range 0.8516 - 4.700
    Shares Outstanding 4,063,081
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Q2 2024 Financial Results, Provides Business Update
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Predictive Oncology Reports Second Quarter 2024 Financial Results and Provides Business Update
    Company to host investor call and webcast today, August 14th, at 8:30am EDT 
    From Predictive Oncology Inc.
    Via GlobeNewswire

    Performance

    YTD
    -74.47%
    -74.47%
    1 Month
    -30.76%
    -30.76%
    3 Month
    -56.83%
    -56.83%
    6 Month
    -73.53%
    -73.53%
    1 Year
    -79.45%
    -79.45%

    More News

    Read More
    POAI Stock Earnings: Predictive Oncology Reported Results for Q2 2024
    Via InvestorPlace
    BioMedNewsBreaks — Predictive Oncology Inc. (NASDAQ: POAI) Announces Expansion of Live-Cell Tumor Platform Applications
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Is Predictive Oncology (POAI) Stock Up 70% Today?
    Via InvestorPlace
    Predictive Oncology Expands the Application of its Live-Cell Tumor Platform to De-Risk Drug Discovery and Accelerate Pipeline Development
    From Predictive Oncology Inc.
    Via GlobeNewswire
    AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Schedules Release of Q2 2024 Financial Results, Conference Call
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Predictive Oncology to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024
    From Predictive Oncology Inc.
    Via GlobeNewswire
    Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    AINewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Enters into $1.2M Agreement for Exercise of Warrants
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Predictive Oncology Announces Exercise of Warrants for $1.26 Million Gross Proceeds
    From Predictive Oncology Inc.
    Via GlobeNewswire
    Why Edwards Lifesciences Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Why Predicitive Oncology Stock Is Soaring
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
    Via Benzinga
    Dow Jumps 200 Points; Honeywell Trims Profit Outlook
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Expands Its AI/ML Driven Platform to Include Novel Oncology Biomarker Discovery
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Predictive Oncology Enters Biomarker Discovery Market After Successful Retrospective Ovarian Cancer Study Yields Compelling Results
    From Predictive Oncology Inc.
    Via GlobeNewswire
    7 F-Rated Growth Stocks to Avoid Right Now: June 2024
    Via InvestorPlace
    InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Unveils Novel Technology, Eyes Significant Partnership Opportunities
    Via Investor Brand Network
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
    From Predictive Oncology Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Launches Novel Technology to Accelerate Cancer Drug Discovery, Development
    Via Investor Brand Network
    Topics Animal Testing Artificial Intelligence
    Exposures Animal Testing Artificial Intelligence
    Predictive Oncology Launches Novel 3D Cell Technology to Accelerate Cancer Therapeutic Drug Discovery
    From Predictive Oncology Inc.
    Via GlobeNewswire
    TinyGemsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) CEO to Participate at Upcoming BIO International Convention 2024
    Via Investor Brand Network
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Why Bank of Montreal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.